Valion Bio, Inc. Current Assets
Valion Bio, Inc. (VBIO) had Current Assets of $3.38 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $3.38M.
- 2026-03-31: Assets, Current $8.65M.
- 2025-12-31: Assets, Current $13.01M.
- 2025-09-30: Assets, Current $3.74M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.38M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $8.65M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $13.01M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $3.74M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.84M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.26M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.64M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $3.16M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $4.66M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.83M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $4.65M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $6.46M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $4.00M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $6.48M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $5.31M 10-K · filed 2024-03-25 | $5.29M 10-K · filed 2023-03-31 |
| 2022-09-30 | $7.59M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $10.37M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $12.00M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $14.29M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |